Page 5 - Casi Hill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Casi hill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Casi Hill Today - Breaking & Trending Today

CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note published on Wednesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright raised their target price on CASI Pharmaceuticals from $10.00 to $12.00 and gave the company a buy rating in a research […] ....

United States , Renaissance Technologies , Virtu Financial , Pharmaceuticals Inc , Citigroup Inc , Susquehanna International Group , Pharmaceuticals Price Performance , Pharmaceuticals Daily , Free Report , Get Free Report , International Group , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

CASI Pharmaceuticals (NASDAQ:CASI) Share Price Passes Above Two Hundred Day Moving Average of $3.93

CASI Pharmaceuticals, Inc. (NASDAQ:CASI – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $3.93 and traded as high as $5.50. CASI Pharmaceuticals shares last traded at $5.42, with a volume of 23,090 shares trading hands. Analyst Upgrades and Downgrades Several […] ....

United States , Susquehanna International Group , Renaissance Technologies , Virtu Financial , Citigroup Inc , Pharmaceuticals Daily , Pharmaceuticals Stock , Pharmaceuticals Inc , Casi Pharmaceuticals Inc , Get Free Report , International Group , Casi Pharmaceuticals , Nasdaq Casi ,

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright raised their price target on CASI Pharmaceuticals from $10.00 to $12.00 and gave the stock a buy rating in a […] ....

United States , Renaissance Technologies , Pharmaceuticals Inc , Virtu Financial , Pharmaceuticals Daily , Citigroup Inc , Susquehanna International Group , Pharmaceuticals Stock Performance , Free Report , Get Free Report , International Group , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,

CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright boosted their target price on CASI Pharmaceuticals from $10.00 to $12.00 and gave the company a buy rating in a research […] ....

United States , Pharmaceuticals Inc , Citigroup Inc , Pharmaceuticals Price Performance , Renaissance Technologies , Susquehanna International Group , Virtu Financial , Pharmaceuticals Daily , Free Report , Get Free Report , International Group , Casi Pharmaceuticals , Nasdaq Casi , Initiated Coverage , Stocknews Com ,